1. Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nature Rev. Cancer 4, 253–265 (2004).
2. Cortes, J. & Baselga, J. Targeting the microtubules in breast cancer beyond taxanes: the epothilones. Oncologist 12, 271–280 (2007).
3. Bollag, D. M. et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325–2333 (1995).
4. Lee, F. Y. et al. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clin. Cancer Res. 7, 1429–1437 (2001).
5. Food and Drug Administration. FDA labelling information [ online ], (2007).